Filing Flows

Filing Flows › Agape ATP (ATPC) › Q2 2026 › vs Q1 2026

Agape ATP (ATPC) Q2 2026 vs Q1 2026 (quarter over quarter)

Agape ATP's revenue fell $165K (-60%) from $274K in Q1 2026 to $109K in Q2 2026. The biggest changes: Product Health Therapies −$198K (-93%); Health and Wellness Services +$41K (+108%); Skin Care and Health Products Segment −$6K (-32%).

Agape ATP, Q2 2026: revenue $109K (-77% year over year), operating margin -505.0%, net earnings $153K, operating cash flow −$110K. The chart draws each line against Q1 2026, the increases inside each band.

Agape ATP: what changed, Q2 2026 vs Q1 2026Agape ATP: what changed, Q2 2026 vs Q1 2026Net earnings$481KOther income, net$298KOperating costs−$291KCash used in operations−$284KGeneral & admin−$266KProduct Health Therapies−$198KOperating cash sources$196KWorking capital & other$193KCosts & expenses−$138KIncome tax benefit$56K

Every line

LineQ2 2026Q1 2026Change%
Energized Mineral Concentrate$8K$11K−$3K-26%
Skin Care and HealthCare Products$6K$9K−$4K-38%
Skin Care and Health Products Segment$14K$20K−$6K-32%
Health and Wellness Services$80K$38K$41K+108%
Product Health Therapies$16K$214K−$198K-93%
Revenue$109K$274K−$165K-60%
Other income, net$635K$336K$298K+89%
Income tax benefit$69K$13K$56K+422%
Costs & expenses$813K$951K−$138K-15%
Operating costs$660K$951K−$291K-31%
Net earnings$153K−$328K$481K—
Cost of revenue$97K$114K−$17K-15%
Sales & marketing$30K$37K−$7K-18%
General & admin$529K$795K−$266K-33%
Other operating costs$3K$5K−$2K-31%
Operating cash sources$263K$67K$196K+292%
Cash used in operations$110K$395K−$284K-72%
Working capital & other$263K$70K$193K+277%

Questions

How much did Agape ATP's revenue grow quarter over quarter in Q2 2026?

Agape ATP's revenue fell $165K (-60%) from $274K in Q1 2026 to $109K in Q2 2026.

What drove Agape ATP's revenue change in Q2 2026?

Product Health Therapies −$198K (-93%); Health and Wellness Services +$41K (+108%); Skin Care and Health Products Segment −$6K (-32%).

Q2 2026 results → · Compare in the interactive Sankey →